secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sigyn Therapeutics, Inc. (SIGY)
CIK:        0001642159
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0001493152-24-004320
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sigyn Therapeutics effects 1-for-40 reverse stock split effective Jan 31, 2024
------------------------------------------------------------------------------

- Reverse stock split ratio of 1-for-40 effective 12:01 a.m. ET on January 31, 2024.
- Post-split shares outstanding ~1,221,043; pre-split shares were ~48.8 million.
- No fractional shares; holders rounding up to next whole share automatically.
- All outstanding equity awards and warrants proportionately adjusted for the split ratio.
- New CUSIP number is 82674U 205; trading symbol remains SIGY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642159/000149315224004320/0001493152-24-004320-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642159/000149315224004320/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-004320

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer